Loading
Latest filing published 23 Apr 2019 for Insys Therapeutics, Inc..
No signal scores available.
Elizabeth Bohlen is a declared insider of Insys Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 7 August 2018 to 4 March 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 23 April 2019 came the latest disclosure, a share grant in Insys Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 46 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations